Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next
New York, January 12, 2026, 09:55 EST — Regular session Moderna (MRNA.O) shares dropped about 2% to $33.60 early Monday after the biotech forecasted around $1.9 billion in revenue for 2025 and lowered its GAAP operating-expense forecast for that year—the